Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$27,000.00
Global picture of concurrent attention deficit and hyperactivity disorder and amphetamine-type stimulant use disorder
EF 2024-25
Résumé
Amphetamine-type stimulant use disorder (ATSUD) and attention deficit and hyperactivity disorder (ADHD) contributes to the global burden of disease worldwide. ADHD diagnosis can greatly impact the evaluation, management and evolution of ATSUD, but our understanding of the interaction between the disorders is complexify by cross-cultural and methods differences in the identification of ADHD worldwide. While estimates have been established for both disorders, global prevalence of comorbid ADHD and ATSUD remains unknown. Here, a systematic review and meta-analysis will be produced to estimate ADHD prevalence among people living with ATSUD while accounting for possible differences across methods and regions. ADHD diagnosis should be prevalent among ATSUD samples, while observed variance in reported estimates should be associated to sociodemographic and methods differences across the literature. A search will be conducted by a librarian on Medline, Embase, PsycINFO and CINAHL to retrieve articles published since 1999 that provided ADHD proportions among participant diagnosed with ATSUD using the DSM, ICD or validated proxy measures. Two independent reviewers will assess eligibility and extract outcomes in duplicate on Covidence based on PRISMA-2020 guidelines. ADHD prevalence estimates will be pooled and analyzed using random-effect proportional meta-analysis. Sources of heterogeneity will be evaluated using sub-group, bivariate and multivariate analysis. Based on feasibility, covariates will include sociodemographic and methodological parameters, as well as ADHD symptom severity of symptoms and ATS use factors. This project will be impactful as results could inform public health agencies during the development of new prevention and resource allocation strategies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530019
Name
Bissonnette Anne-Marie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Global picture of concurrent attention deficit and hyperactivity disorder and amphetamine-type stimulant use disorder
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amphetamine; Attention Deficit And Hyperactivity Disorder; Concurrent Disorders; Cross-Cultural Analysis; Epidemiology; Mental Health; Meta-Analysis; Methamphetamine; Stimulant Use Disorder; Systematic Review
Abstract
Amphetamine-type stimulant use disorder (ATSUD) and attention deficit and hyperactivity disorder (ADHD) contributes to the global burden of disease worldwide. ADHD diagnosis can greatly impact the evaluation, management and evolution of ATSUD, but our understanding of the interaction between the disorders is complexify by cross-cultural and methods differences in the identification of ADHD worldwide. While estimates have been established for both disorders, global prevalence of comorbid ADHD and ATSUD remains unknown. Here, a systematic review and meta-analysis will be produced to estimate ADHD prevalence among people living with ATSUD while accounting for possible differences across methods and regions. ADHD diagnosis should be prevalent among ATSUD samples, while observed variance in reported estimates should be associated to sociodemographic and methods differences across the literature. A search will be conducted by a librarian on Medline, Embase, PsycINFO and CINAHL to retrieve articles published since 1999 that provided ADHD proportions among participant diagnosed with ATSUD using the DSM, ICD or validated proxy measures. Two independent reviewers will assess eligibility and extract outcomes in duplicate on Covidence based on PRISMA-2020 guidelines. ADHD prevalence estimates will be pooled and analyzed using random-effect proportional meta-analysis. Sources of heterogeneity will be evaluated using sub-group, bivariate and multivariate analysis. Based on feasibility, covariates will include sociodemographic and methodological parameters, as well as ADHD symptom severity of symptoms and ATS use factors. This project will be impactful as results could inform public health agencies during the development of new prevention and resource allocation strategies.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bissonnette, Anne-Marie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~